IndiaTickerLatest filing: Analysts/Institutional Investor Meet/Con. Call Updates - Tatva Chintan Pharma Chem Limited
ObservedCompany dossier
Tatva Chintan Pharma
NSE:TATVA · ISIN INE0GK401011
- Close
- ₹1,744.4 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Tatva Chintan Pharma
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹85.9 Cr · PAT ₹0.1 Cr.
Exchange XBRLLatest ownership: promoter group 72.02% and public 27.98% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Tatva Chintan Pharma Chem Limited
NSE · conference call
Observed
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Tatva Chintan Pharma Chem Limited
NSE · conference call
Observed
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Tatva Chintan Pharma Chem Limited
NSE · conference call
Observed
Source filing Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
BSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹85.9 Cr
- Profit after tax
- ₹0.1 Cr
- EPS
- ₹0.06
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 72.02%
- Public
- 27.98%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL